Post by Eliassen Group

Are full-service CROs still the right fit for today’s clinical trials? Our survey of 500 life sciences executives shows a clear shift: sponsors aren’t rethinking whether to outsource—but how. Many are moving toward FSP models for greater flexibility, visibility, and specialized expertise—without giving up control. The future of outsourcing isn’t one-size-fits-all. It’s strategic. Read more: https://lnkd.in/en8Auy6S #ClinicalResearch #Pharma #Biotech #ClinicalTrials #Outsourcing #FSP #LifeSciences